home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Moving In On Drug Resistance

 
  April, 3 2008 8:43
your information resource in human molecular genetics
 
     
People with weakened immune systems - such as transplant recipients or cancer patients undergoing chemotherapy - are often plagued by fungal infections. Antifungal drugs do not always work because some organisms can pump them out of their cells before they do any damage. A paper in Nature reveals a mechanism of how such drugs have the unwanted effect of boosting the fungus' arsenal of pumps used to fight them off.

Anders Näär and colleagues have identified a crucial protein - known as Pdr1p - in fungi such as yeast (Saccharomyces cerevisiae) and the organism responsible for thrush-like infections (Candida glabrata) that directly binds the drug once it has gained entry into the cell. This binding stimulates the fungus to step up production of its defensive pumping gear, and the drug is ejected.

Pdr1p can bind different types of antifungal drug, giving rise to multidrug resistance. The authors hope that understanding the mechanism behind this resistance will help in the design of drugs to thwart it.

CONTACT

Anders Näär (Harvard Medical School, Charlestown, MA, USA)
E-mail: naar@helix.mgh.harvard.edu

Andre Goffeau (Universite de Louvain, Louvain-la-Neuve, Belgium)
E-mail: andre.goffeau@scarlet.be

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.